bilirubinaemia (bilirubin level >15 mg/100 ml or 255 'mol/1).2 The incidence of hyperbilirubinaemia in glucose-6-phosphate dehydrogenase-(G6PD) deficient infants is even higher. 3 The jaundice in such infants is also more prolonged.
The increased incidence and severity of neonatal jaundice in G6PD-deficient infants, often causing kernicterus in the past, have been partly ascribed to the cultural practices of the local Chinese in the care of newborn infants which in some cases have used agents potentially haemolytic for G6PD-deficient red cells.3 However, with better education and dissemination of knowledge, such practices have declined to negligible levels. It was therefore thought that a re-evaluation of neonatal jaundice in relation to the G6PD status of infants would be timely. The present paper is the result of such a study.
Methods and materials
In the Kandang Kerbau Hospital, Singapore, routine screening of all cord bloods for G6PD deficiency using a modification of Bernstein The results were subjected to statistical evaluation.
Results
Three hundred and sixty-two neonates were studied (Table) . All the infants were in satisfactory condition immediately after delivery. Feeds were begun at about 6 hours of age. All the G6PD-deficient and intermediate infants were formula-fed except for 5 (4 in the deficient group) who were breast fed. Of the normal infants only 10 were breast fed.
In the G6PD-deficient group of infants, the bilirubin levels of those delivered from amniotomy and oxytocin-induced labours were not appreciably different from those delivered from spontaneous labours or from spontaneous labours augmented by oxytocin; similar findings were observed with the group of infants delivered by assisted or operative methods when compared with those delivered normally either spontaneously or otherwise. The findings were the same in the G6PD intermediate and normal groups of infants. In the G6PD normal group, the bilirubin levels of the breast-fed infants were again observed to be not significantly different from those of the formula-fed infants. (Table) . The bilirubin levels rose steadily until the 4th day when peak values were reached in all three groups (Figure) . The rate of bilirubin rise in the control group was initially rapid resulting in its bilirubin level rising beyond that of the G6PD intermediate group by the 3rd day of life.
The bilirubin values of the G6PD-deficient group however, remained significantly higher than those of the normal group throughout the first 5 days of life (P<00Ol for the first 4 days, P<0 02 for the 5th day). There was also a significant difference in bilirubin values between the G6PD-deficient and intermediate groups from the 1st to 14th day of life at which time the bilirubin level of the G6PD-deficient group had declined to 3-9 mg/100 ml (67 ,umol/l), a value already reached by the G6PD intermediate group on the 8th day of life. The bilirubin level had declined so much in both groups by the 21st day of life that there was very little difference between the values of the two groups (0-9 >P>0-8).
In the G6PD-deficient group, 48 of the 220 infants developed hyperbilirubinaemia compared with 12 of the 116 normal infants, a difference that was significant (P<0-02). The incidence of hyperbilirubinaemia in the G6PD intermediate group, 2 of the 26 infants, was however not significantly different from that of the G6PD-deficient group (0-1 > P>0O5)orthecontrolgroup(0 7 > P>0 6).
The direct acting bilirubin did not exceed 1 mg/100 ml (17 ,tmol/l) in any of the random samples determined.
The Ist day Hb value of the G6PD-deficient group was the lowest of the three groups. It was (Table) . Discussion
The present study is believed to be the first to document bilirubin values under standard conditions in G6PD-deficient and intermediate infants continuously for the first 3 weeks of life. It demonstrates that even in a hospital environment free from agents potentially haemolytic to G6PD-deficient cells, the bilirubin levels of G6PD-deficient Chinese infants were still significantly higher than those of G6PD intermediate or normal infants. Furthermore, the incidence of hyperbilirubinaemia in G6PD-deficient infants (220%) was more than twice that of normal infants (95 %), and thrice that of G6PD intermediate infants (7 7 %) though in the last group the numbers were probably too few for the comparison to be significant. Had the infants with hyperbilirubinaemia been allowed to continue in the study group with no treatment, the bilirubin levels of the G6PD-deficient group would have been expected to be even higher, as observed in a previous study3 where exchange transfusion was resorted to only at a much higher bilirubin level. The jaundice of G6PD-deficient infants also tended to be more prolonged, the value at the end of the second week of life being comparable with that of G6PD intermediate infants at the end of the first week of life. However, unlike a previous study,3 hyperbilirubinaemia only occurred within the first week of life in all cases regardless of G6PD status under the controlled conditions of this study. Nor did mode of labour, method of delivery, manner of feeds, or sex ratio apparently have any significant effect on the daily bilirubin values.
In the group of G6PD normal control infants, the bilirubin levels were comparable with those of a previous study' made at a time when cultural practices were still fairly common in Singapore. The decline in such practices apparently had no effect on the bilirubin levels of normal healthy infants. This marked 'physiological' jaundice in the apparent absence of increased haemolysis suggests an underlying hepatic mechanism. It appears to be an ethnic characteristic of Chinese infants.
Although the initial bilirubin level of the G6PD-intermediate group of infants was higher than that of the control group, it had fallen below that of the control group by the 3rd day of life. From the trend of the bilirubin levels in the two groups, it is likely that the subsequent course of the bilirubin values of w r 0 w t S . 
